All-Spectrum Transradial Approach: Safer than Femoral

Original Title: Radial vs femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: a meta-analysis of randomized trials.

Reference: Ferrante G et al. J Am Coll Cardiol Intv. 2016; Epub ahead of print.

 

acceso_radial_finalRegardless the type of coronary syndrome, the transradial approach results in lower mortality and complications compared to the femoral.

Some studies (especially on chronic and stable patients) have seen contradicting results as regards the advantages of the transradial approach over the femoral, which is why this meta-analyzis of 24 studies was carried out, involving over 22,843 patients with PCI in the context of ACS

  • without ST elevation
  • with ST elevation
  • in stable patients

The transradial approach showed lower risk of all cause death (OR 0.71, CI 95% 0.58 to 0.87) and lower risk of combined cardiovascular events (OR 0.84; CI 95% 0.75 to 0.94) in the general population.

The transradial approach was also associated to lower major bleeding rate (OR 0.53; CI 95% 0.42 to 0.65) and lower major vascular complications rate (OR 0.23; CI 95% 0.16 to 0.34).

Other important data resulting from this work is that MI and stroke rates resulted similar for both vascular access sites.

When analyzing outcomes according to clinical presentation, stable patients are those who benefit most from reduced major bleeding. In the group of ACS patients, ST elevation MI patients saw the greatest benefit with transradial approach.

Lastly, the experienced centers obtained the highest benefits vs. femoral approach.

 

Conclusion

The transradial approach reduces mortality and combined events, and improves safety because of reduced bleeding and vascular complications, compared to the femoral access.

 

Editorial Comment

The benefit of the transradial approach seems out of question; however, a great randomized study would be useful to understand the mechanisms behind this advantage. Reduced major bleeding seems to be the main reason behind mortality decrease, though it may not be enough: there may be other, hidden mechanisms involved.

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or any ideas here below.

More articles by this author

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...